UBC project examines the LGBT experience with breast and gynecological cancers

August 3, 2012, University of British Columbia

Researchers at the University of British Columbia are leading the first nationwide project on how sexual and gender minorities experience cancer, highlighting previously overlooked communities’ perspectives on cancer care.

Led by Prof. Mary Bryson, Director of the Institute for Gender, Race, Sexuality and Social Justice, and funded by the Canadian Institutes for Health Research, the three-year Cancer’s Margins project will look at how lesbian, gay, bisexual and transgender cancer patients and members of their support networks in British Columbia, Manitoba, Ontario, Quebec, and Nova Scotia experience breast and gynecological cancers from and diagnosis to care, treatment and support networks.

Researchers want to understand what individuals value about their care and support networks, how they educate themselves, and what they consider culturally competent care.

“People try to look for health information in communities that reflect themselves,” said Bryson, also a professor in the Faculty of Education.

“We’ve found that these groups don’t have access to cancer health care, or cancer support communities that map onto their own support networks and community values.”

According to Statistics Canada, people are less likely to have a general practitioner and therefore to participate in cancer screening. Canadian GP’s typically have little or no knowledge of the cancer risks these populations face.

According to Bryson, the LGBT experience with breast and gynecological cancers is unique in that typical cancer screening initiatives, cancer treatment and support protocols don’t anticipate the inclusion of sexual .

“A transgender man may still be at risk for developing gynecologic cancers but he may not be participating in regular screening because none of the health promotions and awareness material is directed at him and his GP may be unaware of his risk.”

For more information, visit the ’s Margins website at: www.queercancer.org

Explore further: Wide variation in number of patients GPs refer with suspected cancer

Related Stories

Wide variation in number of patients GPs refer with suspected cancer

July 31, 2012
Information published today by the National Cancer Intelligence Network (NCIN) reveals wide variation across England in the numbers of patients with suspected cancer that GP practices refer to secondary care.

Fear, anxiety and embarrassment stop women going for breast screening

November 9, 2011
(Medical Xpress) -- Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented ...

Bisexual, lesbian women less likely to get pap tests

June 7, 2011
A new study finds that young bisexual and lesbian women are less likely to get Pap tests than straight women, while young bisexual women face a higher risk of being diagnosed with sexually transmitted diseases.

Progress, but no letup: 'Equal rights does not necessarily mean equal lives,' says LGBT activist

July 17, 2012
From the repeal of the military’s “don’t ask, don’t tell” policy, to the expansion of marriage rights in several states, to the passing of a federal hate crimes prevention act, the past several years ...

BreastScreen: balancing benefits and harms

November 4, 2011
New research has questioned the relative impact of mammographic screening in reducing deaths from breast cancer, concluding that it is not responsible for most of the recent reduction in mortality rates and may in fact cause ...

Patient navigators might reduce disparities in cancer care

August 17, 2011
Past research shows that minorities suffer higher rates of advanced cancer and deaths from all types of cancer compared to whites. According to an article in the August issue of Cancer, the role of “patient navigator” ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.